IP Library Granted Patent US 11,533,934
Granted Patent B2
US 11,533,934 · App. 16/954,090 · Granted Dec 27, 2022

Animal feed material

Inventors: Tim Goossens (Dendermonde, BE); Filip Florimond Magdalena Van Immerseel (Dendermonde, BE); René Kwakkel (Dendermonde, BE); Pierre Clément Antoine Moquet (Dendermonde, BE); Lonneke Onrust (Dendermonde, BE)
Assignee: NUTRIAD INTERNATIONAL
A23K20/163A23K20/195A23K50/75A61K31/717A61P31/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,533,934
App. No.
16/954,090
Granted
Dec 27, 2022
Kind
B2
Abstract

A feed material for livestock is effective in prevention and/or treatment of pathogenic infections in livestock and/or in increasing efficiency in livestock production. Enteral administration of polysaccharide butyryl esters to livestock animals results in increased butyrate concentrations in the lower intestinal tract. This leads amongst others to a reduced presence of pathogens in the lower intestinal tract and feces and superior growth performance results compared to other butyrate formulations or products. The feed material provides polysaccharide butyryl esters, compositions, such as feed additives and/or feed, having the polysaccharide butyryl esters, as well as the uses of the polysaccharide butyryl esters as feed additive, e.g. for preventing or treating pathogenic infections in livestock and/or in increasing efficiency in livestock production.

Claims (13)

1. A non-therapeutic method for

decreasing the feed conversion ratio,

increasing the life weight, or

increasing the average daily weight gain,

in livestock animals that are in good or normal health, said method comprising the step of administering in admixture with the animal feed, a cellulose butyryl ester which further comprises acetyl ester groups, wherein the cellulose butyryl ester includes a number average molar mass of 2000-1000000 g/mol,

wherein said cellulose butyryl ester has an acetyl content selected from at least 1 wt % and at most 10 wt %.

2. The non-therapeutic method according to claim 1 ,

wherein the average number of butyryl groups per monosaccharide unit is within the range of 0.1-4.

3. The non-therapeutic method of claim 1 , wherein the cellulose butyryl ester is administered in the inhibition or treatment of pathogen infection, wherein pathogen is selected from one or more of bacteria, eimeria, viruses, and fungi.

4. The non-therapeutic method according to claim 1 ,

wherein the animal to be administered is a poultry species.

5. The non-therapeutic method of claim 1 , wherein said cellulose butyryl ester has an acetyl content of at least 2%.

6. The non therapeutic method of claim 1 , wherein said cellulose butyryl ester has an acetyl content of at most 8%.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Oct 24, 2022
From: NUTRI-AD INTERNATIONAL NV; NUTRIAD EUROPE
To: NUTRIAD INTERNATIONAL
Reel/Frame 061757/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2022
From: GOOSSENS, TIM; VAN IMMERSEEL, FILIP FLORIMOND MAGDALENA; KWAKKEL, RENÉ; MOQUET, PIERRE CLÉMENT ANTOINE; ONRUST, LONNEKE
To: NUTRI-AD INTERNATIONAL
Reel/Frame 061491/0725 →
Priority Claims (1)
BE 2017/5984 · Dec 22, 2017 · national
Continuity (1)
Related Publication 20210186057A1 · Jun 24, 2021